Figure 5.
Low-dose chidamide enhanced CTLA4 expression in splenocytes from active ITP mice and in CD4+CD25+Foxp3+ Treg cells from PBMCs from ITP patients. (A) Low-dose chidamide enhanced CD4+CTLA4+ T cell numbers and percentages in splenocytes from active ITP mice. (B) Low-dose chidamide enhanced CTLA4 expression in CD4+CD25+FOXP3+ Treg cells in PBMCs from ITP patients. *P < .05, **P < .01.

Low-dose chidamide enhanced CTLA4 expression in splenocytes from active ITP mice and in CD4+CD25+Foxp3+ Treg cells from PBMCs from ITP patients. (A) Low-dose chidamide enhanced CD4+CTLA4+ T cell numbers and percentages in splenocytes from active ITP mice. (B) Low-dose chidamide enhanced CTLA4 expression in CD4+CD25+FOXP3+ Treg cells in PBMCs from ITP patients. *P < .05, **P < .01.

Close Modal

or Create an Account

Close Modal
Close Modal